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RESUMO 
 
A degenerescência macular relacionada com a idade (DMRI) é a principal causa 
de cegueira na população com idade superior a 60 anos no mundo ocidental. Apesar 
dos mecanismos moleculares associados à DMRI não serem ainda bem conhecidos, o 
stress oxidativo parece desempenhar um papel fundamental no desenvolvimento e 
progressão da doença. Alguns estudos recentes sugerem ainda que esta patologia 
apresenta uma importante componente inflamatória. Recentemente, o nosso 
laboratório demonstrou que a inactivação oxidativa do proteassoma pode contribuir 
para alterações celulares e fenotípicas associadas à DMRI. Esta disfunção de 
componentes críticos da VUP (via da ubiquitina-proteassoma) poderá constituir um 
novo mecanismo que permite associar a lesão oxidativa da retina à expressão de 
características fenotípicas próprias da DMRI, nomeadamente o aumento da produção 
de mediadores inflamatórios, acumulação de drusen (devido à diminuição no 
recrutamento de macrófagos) e neovascularização da retina. 
Estudos anteriores, incluindo estudos do nosso laboratório, demonstraram que a 
acumulação de produtos da oxidação do colesterol, ou oxiesteróis, em tecidos 
oculares, como o cristalino e a retina, está associada ao processo de envelhecimento. 
Mais, os oxiesteróis levam a um aumento na produção de citocinas pró-inflamatórias 
em vários tipos celulares, incluindo o epitélio pigmentado da retina (EPR). Este 
aumento poderá contribuir para a componente inflamatória de diversas doenças 
relacionadas com a idade, como a DMRI.  
No entanto, os mecanismos moleculares que regulam a expressão de citocinas 
inflamatórias nestas condições não são ainda claros. Assim, o principal objectivo deste 
estudo foi esclarecer os mecanismos moleculares através dos quais os oxiesteróis 
aumentam a produção de IL-8 no EPR. Para isso, uma linha celular humana do EPR 
(ARPE-19) foi exposta a diferentes oxiesteróis. 
A exposição das células ARPE-19 ao 25-hidroxicolesterol (25-OH) resultou no 
aumento da secreção de IL-8, ao passo que os outros oxiesteróis testados diminuíram 
os níveis de IL-8. Consistente com um efeito a nível da expressão genética da IL-8, o 
tratamento das células ARPE-19 com 25-OH aumentou os níveis de RNA para esta 
citocina. Deve ainda acrescentar-se que o 25-OH aumentou a produção de IL-8 no 
EPR por um mecanismo independente do stress oxidativo ou da inactivação do 
proteassoma. 
xi 
 
 
 
O tratamento das células ARPE-19 com 25-OH resultou ainda na activação da 
ERK, mediada pela PI3K. Consistente com este mecanismo, a inibição destas vias de 
sinalização diminuiu significativamente a produção de IL-8 em resposta ao 25-OH. 
No seu conjunto, os resultados aqui apresentados permitem propor um novo 
mecanismo molecular através do qual o 25-OH aumenta a produção de IL-8 em 
células do EPR. 
Assim, este estudo pode constituir uma contribuição importante para esclarecer 
os mecanismos moleculares que conduzem à inflamação no RPE, que é uma 
componente importante para doenças degenerativas da retina associadas ao 
envelhecimento, incluindo a DMRI.  
 
Palavras-Chave: Degenerescência macular relacionada com a idade, inflamação, 
interleucina-8, PI3K, ERK, 25-hidroxicolesterol. 
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ABSTRACT 
 
Age-related macular degeneration (AMD) is the main cause of blindness in the 
western world in the population over 60 years of age. While the cause of AMD is 
currently not known, it has been suggested that multiple factors are involved including 
environmental, nutritional and genetic factors. Most of these risk factors appear to have 
oxidative stress as a common denominator. Recent findings further suggest a role for 
inflammation in the pathogenesis of AMD. We have recently demonstrated that the 
oxidative impairment of the proteasome is a mechanistic link between oxidative stress 
and inflammation. These observations provide a new association between retinal 
oxidative insult and AMD-like phenotypes, such as the increased production of 
inflammatory cytokines, like interleukin-8 (IL-8). 
Several studies, including some from our laboratory, indicate that oxysterols, 
which result from cholesterol oxidation, accumulate in ocular tissues, such as the lens 
and retina, upon aging. Age-related oxysterols accumulation may account, at least in 
part, for the inflammatory component of several age-related diseases, as they increase 
the production of inflammatory cytokines, such as IL-8, in several cell types, including 
the retinal pigment epithelium (RPE).  
Nevertheless, the molecular mechanisms underlying the increased IL-8 
production by oxysterols in RPE are still unclear. Therefore, the main goal of this study 
was to elucidate the molecular mechanisms whereby cholesterol oxides increase the 
production of IL-8 in the RPE. For that purpose, a human RPE cell line (ARPE-19) was 
exposed to different oxysterols. 
Exposure of ARPE-19 cells to 25-hydroxycholesterol (25-OH) resulted in an 
increase in IL-8 secretion, whereas the other oxysterols tested decreased IL-8 levels. 
Consistent with an effect of 25-OH on IL-8 gene expression, treatment of ARPE-19 
cells with 25-OH increased the levels of IL-8 mRNA. Furthermore, 25-OH increased IL-
8 production in RPE by a mechanism that does not involve oxidative stress nor 
inactivation of the proteasome. 
Treatment of ARPE-19 cells with 25-OH also resulted in the PI3K-dependent 
ERK activation. Furthermore, blocking any of these signaling pathways prevented the 
IL-8 up-regulation induced by 25-OH.  
Taken together, the results presented in this thesis elucidate a novel signaling 
pathway whereby 25-OH increases IL-8 production in RPE cells. 
xiii 
 
 
 
By understanding the molecular mechanisms underlying the inflammatory 
properties of oxysterols in the retina and its contribution to AMD, it might be possible to 
envision novel therapeutic targets for this pathology.   
 
Keywords: Age-related macular degeneration, inflammation, interleukin-8, PI3K, ERK, 
25-hydroxycholesterol. 
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1. INTRODUCTION 
 
1.1. Anatomy and physiology of the eye 
 
The ocular globe is constituted by six muscles involved in the ocular movements 
and three concentric layers working together to provide vision, nutrition and protection 
to the eye (1). 
The exterior layer is constituted by the cornea and sclera. The medium or 
vascular layer is formed by the iris, choroid, corium and uvea. The interior layer is 
composed by the retina (Figure 1) (1; 2). 
 
 
 
 
 
 
 
 
 
 
 
The human retina is approximately 0.2 mm thick, and has an area of 
approximately 1100 mm2. Each retina possesses about 200 million neurons. The optic 
disc, where neuronal cells merge to form the optic nerve, is the only area of the retina 
that is “blind” as it lacks photoreceptors. It appears as an oval white area of 3 mm2. 
Temporal to this disc is the macula (3).  
The macula is the central posterior portion of the retina and has the highest 
concentration of photoreceptors, which facilitate central vision and provides high-
resolution visual acuity (4; 5; 6; 7). In the center of the macula lays the fovea, a 
depression with high concentration of cone cells, responsible for the central vision (5). 
Figure 1: The structure of human eye (135). 
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Although the retina is a complex multilayered structure, it can be functionally 
divided in two parts: the neuronal retina, composed by the photoreceptors (cones and 
rods) and their neuronal connections, is responsible for the phototransduction process; 
the retinal pigment epithelium (RPE) and its basal lamina known as Bruch’s membrane 
maintain the integrity between retina and choroid (Figure 2) (5; 8). 
The choroid is a vascular tunica lying between the sclera and retina and its 
function is to provide oxygen and nourishment to the outer layers of the retina (4; 8). 
Bruch’s membrane is a semi-permeable exchange barrier that separates the RPE 
from the choroid (4; 8; 9). 
 
 
 
 
 
 
 
 
The RPE is a monolayer of pigmented cells located between the choriocapillaris 
and the photoreceptors outer segments (POS) and forms part of the blood-retinal 
barrier (BRB) (8; 9; 10). RPE cells receive their name from the melanin pigment 
granules (melanosomes) located in the apical cytoplasm (9). These pigments are 
responsible for absorbing the light focused by the lens in the retina (10). 
The RPE is essential for visual function, providing multiple functions that support 
normal photoreceptor function (Figure 3).  
The RPE transports ions, water and metabolic end products from the subretinal 
space to the blood and takes up nutrients such as glucose, retinal and fatty acids from 
the blood, delivering them to the photoreceptors (9; 10).  
The RPE also plays an important role in the visual cycle, by participating in the 
light-dependent cycling and reisomerization of retinal (the vitamin A derivative that 
serves as the chromophore for the visual pigments). Retinal is constantly exchanged 
between the photoreceptors and RPE. Photoreceptors are unable to reisomerize all-
Figure 2: Schematic diagram of the retina and choroid (CH). The choroidal vasculature is 
at the top and the inner retina is at the bottom. CH, choroid; BM, Bruch’s membrane; RPE, 
retinal pigment epithelium, OS, outer segments of retina; IS, inner segments of retina. Adapted 
from Rattner et al. (8). 
25-Hydroxycholesterol increases IL-8 production in retinal pigment epithelial cells by 
activation of PI3K and ERK pathways 
 
3 
 
trans-retinal, formed after photon absorption, back into 11-cis-retinal. To maintain the 
photoreceptor excitability, retinal is transported to the RPE, reisomerized to 11-cis-
retinal and transported back to photoreceptors. This process is known as the visual 
cycle of retinal (8; 9; 10).  
Another RPE function is the maintenance of photoreceptor excitability by the 
phagocytosis of the POS (10). Photoreceptors are exposed to intense levels of light. 
This leads to accumulation of photo-damaged proteins and lipids. Therefore, the 
concentration of light-induced toxic substances inside the photoreceptors increases 
over time (10). To maintain the excitability of photoreceptors, the POS are digested 
daily by the RPE and essential substances, such as retinal, are recycled and returned 
to photoreceptors to rebuild light-sensitive outer segments from the base of the 
photoreceptors (4; 8; 9; 10). The process of phagocytosis must be tightly coordinated 
between the RPE and the photoreceptors in order to maintain a proper photoreceptor 
activity (10).  
In addition, the RPE is able to secrete a variety of growth factors and cytokines, 
which are responsible for maintaining the structural integrity of the retina and 
choriocapillaris (4).  
With such a variety of metabolic and supportive functions, the RPE plays a vital 
role in visual function. Therefore, it is not surprising that a deregulation in any of these 
functions has a critical impact on retinal function and may lead to retinal degeneration, 
loss of visual function and blindness (4; 9; 10; 11). 
 
Figure 3: Summary of retinal pigment epithelium (RPE) functions. PEDF, pigment 
epithelium-derived growth factor; VEGF, vascular epithelium growth factor; Epithel, epithelium.
(10) 
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1.2. Age-related macular degeneration 
 
Age-related macular degeneration (AMD) is the leading cause of blindness 
among elderly population (usually over 60) at industrialized countries and its 
prevalence is likely to rise as a consequence of increasing longevity (6; 12; 13). 
AMD is characterized by degenerative changes in the macula, the central region 
of the retina bearing the highest concentration of photoreceptors (4; 5; 6). Accordingly, 
this degeneration of the macula leads to loss of central vision (6; 13). 
One of the earliest clinical manifestations and pathological features of AMD is the 
formation of drusen (11; 14; 15). Drusen are accumulations of extracellular amorphous 
debris located between the RPE and Bruch’s membrane (6; 8; 11). Drusen can be 
found in healthy individuals over 50 years, but the presence of large or numerous 
drusen confers significant risk for AMD (4; 13; 16).  
AMD can be classified into two major subtypes: the atrophic (or dry form) and 
neovascular (or wet form) (Figure 4). 
The atrophic form is characterized by drusen accumulation, geographic atrophy 
of RPE, and photoreceptor dysfunction and degeneration (Figure 4) (4; 6; 8; 11; 17). 
The dry form is the most common form of AMD, with more than 80% of all the AMD 
patients presenting these phenotypes (11; 18). 
The neovascular form is more debilitating and often follows the atrophic form. 
The key feature of wet AMD is choroidal neovascularization (CNV), the growth of new 
blood vessels from the choroid into the region underlying the RPE or extending past 
the RPE into the subretinal space and retina (Figure 4) (4; 6; 8; 11; 18). This choroidal 
neovascularization can lead to leakage of blood into the subretinal space, which, along 
with RPE atrophy and photoreceptor degeneration, leads to vision loss (4; 11; 17; 18). 
As a multifactorial disease, there isn’t a known cause for AMD. Instead, several 
risk factors have been identified. Some of these include smoking, body mass index, 
diet and light exposure. A number of studies have linked genetics, oxidative stress, 
RPE senescence, hypoxia and many other factors to AMD (4; 5; 6; 8; 13; 14; 19). Still, 
the exact etiology and pathogenesis of the disease remain largely unclear.  
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1.3.  Oxidative Stress and AMD 
 
Oxidative stress, which refers to cellular injury caused by reactive oxygen species 
(ROS), has been proposed to play a causative or contributing role in a large number of 
diseases, such as heart disease, certain types of cancers, neurodegenerative 
disorders, cataract and AMD (20; 21; 22). In fact, a progressive increase of the 
oxidative cellular environment, due to the altered redox homeostasis, appears to be 
one of the hallmarks of the aging process. 
ROS include free radicals, molecules that contain one or more unpaired electrons 
in their orbits, such as superoxide (O-2) and hydroxyl radical (OH.) as well as non-
radicals, such as hydrogen peroxide (H2O2) and singlet oxygen (
1O2) (Figure 5) (20; 23; 
24). Many of these oxygen metabolites occur as byproducts of normal physiology or as 
the result of photochemical reactions (20; 25). An increased oxidative environment 
inside the cell is known to cause cumulative damage to proteins, lipids, and DNA (26). 
 
Figure 4: Comparison between the dry and wet forms of Age-related macular 
degeneration (AMD). Adapted from National Eye Institute (136) 
25-Hydroxycholesterol increases IL
activation of 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
An increasing body of literature indicates that development of AMD is due to 
dysfunction of the RPE (14; 27)
susceptibility of the RPE to oxidative stress
studies suggest that RPE cells can be readily damaged following exposure to an 
oxidative insult (20; 23).  
The retina is an ideal environment for the gener
(20; 23; 25). The metabolic rate and oxygen consumption by the retina is much higher 
than by any other tissue
generation of ROS. Chronic exposure to light may further incr
(28; 31).  
Figure 5: The sources and cellular response to reactive oxygen species (ROS). Oxidant 
production can be triggered by endogenous or exogenous sources. Also, antioxidant 
including catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GPx), 
counteract and regulate overall ROS levels to maintain physiological homeostasis. Lowering 
ROS levels below the homeostatic set point may impair the physiological function of oxidants in 
cellular proliferation and host defense. I
and lead to cell death or to acceleration of ageing and age
-8 production in retinal pigment epithelial cells by 
PI3K and ERK pathways 
 
. This dysfunction may be related with 
 (21; 23; 28; 29; 30). In fact, a variety of 
ation of ROS for several reasons
. This high metabolic rate is usually accompanied by 
ease ROS production
n the same way, increased ROS may also be harmful 
-related diseases (131)
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Physiologically, RPE cells phagocytose and digest POS (10). This unique 
phagocytic function of RPE provides an additional oxidative burden since the shed 
outer segments are extremely rich in polyunsaturated fatty acids (PUFA), which can be 
readily oxidized and can initiate a cytotoxic chain-reaction, producing an abundance of 
ROS. In fact, the process of phagocytosis by the RPE is itself an oxidative stress and 
results in ROS production (20; 31). 
Age-related accumulation of lipofuscin in RPE is another source of oxidative 
stress. Lipofuscin is a mixture of non-degradable protein-lipid aggregates derived from 
ingestion of POS (32). A2E is the major fluorophore of lipofuscin and acts as a 
photosensitizer to generate ROS inside the cells upon exposure to blue light (25; 20; 
33; 34; 35). 
Consistent with a role of oxidative stress in the development of AMD, an 
increasing body of literature indicates also that exposure of RPE cells to oxidative 
stress results in an increase of angiogenic cytokines and growth factors, as well as on 
other features of AMD (20; 21; 36; 37; 38). 
To cope with these toxic oxygen species, the RPE has three lines of defense 
(39). The first line is absorption and filtering of light (31). The RPE contains various 
pigments that are specialized in absorbing different wavelengths. General light 
absorption occurs via melanin in melanosomes (40). Carotenoids lutein and 
zeaxanthin, the macular pigments of retina, absorb blue light (25). The second line of 
defense is made by the antioxidants, both enzymatic and non-enzymatic. In the RPE, 
the major cellular water-soluble non-enzymatic antioxidants found are vitamin C and 
reduced glutathione (GSH). The main lipid-soluble antioxidants include vitamin E, 
retinoids and caratenoids (23). The RPE also contains high amounts of enzymatic 
antioxidants, such as superoxide dismutase (SOD) and catalase (23).The third line of 
defense is the cell’s physiological ability to repair damaged DNA, lipids and proteins 
(10). 
During aging and pathological conditions, the balance between ROS generation 
and ROS clearance appears to be impaired, due to either a reduction in RPE defense 
mechanisms and/or an increase in ROS production (20; 23). Consistent with this, an 
increasing body of literature demonstrates an age-dependent reduction in vitamin E 
and melanosomes in the RPE (41). Therefore, it is likely that aging RPE cells are more 
susceptible to oxidative damage (28). In support of this hypothesis, recent studies have 
shown that mice deficient in Cu,Zn-SOD, an antioxidant enzyme, display typical AMD 
phenotypes (42; 43). 
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Currently, the available experimental data provide solid evidence of increased 
oxidative stress occurring in the retina and RPE upon aging (20; 23; 25; 28; 31). 
However, it remains unclear whether oxidation is a cause or consequence of retinal 
degenerations, such as AMD (20; 31). 
 
1.4. Inflammation and AMD 
 
Inflammation is considered a response set by tissues, as a complex network of 
molecular and cellular interactions directed to facilitate return to physiological 
homeostasis and tissue repair (44).  
Emerging pathological evidence indicates that many age-related diseases, such 
as AMD, atherosclerosis, arthritis and certain types of cancer are associated with an 
inflammatory component (21; 45; 46).  
The activation of redox-sensitive transcription factors may be involved in 
triggering the expression of inflammatory cytokines, thus providing a molecular link 
between oxidative stress and inflammation upon aging (Figure 6) (21; 47; 48). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Major molecular pro-inflammatory pathways involved in aging and age-related 
diseases. RS, reactive species; MAPK, Mitogen-activated protein kinase; NIK, NF-κB kinase; 
IKK, IKβ kinase; AMs, adhesion molecules; iNOS, inducible NO synthase; COX-2, 
cyclooxygenase (47). 
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The complement system is a central part of the innate immunity and its main 
function is to recognize and eliminate invading microorganisms (21; 49). 
The complement system is divided into three main pathways: classical, lectin and 
alternative. The classical pathway is activated by immune complexes (antibody-antigen 
complex); the mannose-binding lectin pathway is activated primarily by mannose and 
N-acetyl glucosamine residues particularly abundant on bacterial cell surfaces, and the 
alternatively pathway is initiated by a variety of substances, including microbial 
surfaces and polysaccharides (50; 51). Overall, activation of these pathways results in 
a pro-inflammatory response including generation of membrane attack complexes 
(MAC), which mediate cell lysis, release of chemokines to attract neutrophils and 
macrophages to the site of damage and enhancement of capillary permeability (43; 50; 
51). A deregulation of the complement, particularly the alternative pathway, results in a 
defective recognition of these microorganisms and leads to an accumulation of toxic 
activation products, which can be formed on the surface of host tissues and structures 
(21). 
An increasing body of literature has reported the presence of components of the 
complement cascade, including C3, C5 and their bioactive fragments C3a, C5a and 
C5b-9 complex (also known as MAC), in drusen from human eyes, including eyes from 
AMD patients (20; 49; 52; 50). The observation that immune complexes, complement 
and/or complement regulatory proteins are present in drusen, both in humans and 
mice, has led to the hypothesis that AMD results from an atypical inflammatory process 
that includes inappropriate complement activation (49; 53; 54). 
Complement factor H (CFH) is a critical negative regulator of the complement 
system (45). CFH regulates activation of the alternative pathway by inhibiting several 
steps of this pathway and promoting degradation of activated complement components 
(50). CFH binds heparin on cell surfaces to prevent complement-mediated damage to 
heparin and the cells bearing them. It also binds C-reactive protein (CRP) to inhibit 
CRP-mediated activation of the alternative pathway in response to damaged tissue (50; 
55; 56). 
Several recent studies have identified a strong association between 
polymorphisms in CFH and in complement factor B (CFB), a positive regulator of the 
alternative pathway of the complement, and an increased risk of AMD (49; 57; 58). 
Accordingly, genetic polymorphisms in CFH and CFB may result in an abnormal up-
regulation of the complement activity and a consequent increase in the inflammatory 
component of AMD (21; 55; 56).  
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Consistent with a role for the complement system in the pathogenesis of AMD, a 
recent report suggests that oxidative stress in RPE can trigger the activation of the 
complement (59). Moreover, complement activation results in an enhanced expression 
of interleukin-8 (IL-8), an important pro-inflammatory and angiogenic cytokine (60). The 
increased expression of IL-8 has also been reported in RPE cells that were fed with 
oxidized POS, further supporting the link between oxidative stress and inflammation 
(36; 37; 61).The increased expression and secretion of IL-8 may account, at least in 
part, for the inflammatory reactions during AMD development (37; 62). 
Monocyte chemotactic protein-1 (MCP-1) is a chemokine involved in monocyte 
infiltration into the sites of inflammation (63). In RPE cells, this chemokine has been 
suggested to play a role in drusen clearance. A recent study showed that deficiency in 
MCP-1 or its cognate receptor CCR-2 leads to AMD-like features in mice, including 
accumulation of lipofuscin and drusen beneath the RPE, photoreceptor atrophy and 
CNV (50; 64).  
The impairment in macrophage recruitment causes accumulation of complement 
components, such as complement regulatory proteins and IgG in the retina. Since 
deposition of complement-related proteins and IgG precedes the accumulation of 
drusen and lipofuscin, it is likely that the AMD-like pathology is due, at least in part, to 
complement activation and immune complex deposition (59; 64). 
However, several studies have demonstrated accumulation of macrophages in 
histologic specimens from patients with AMD, especially in regions of RPE atrophy, 
breakdown of Bruch’s membrane and CNV (43; 50). Moreover, macrophages in CNV 
lesions have been shown to express angiogenic factors, such as vascular endothelial 
growth factor (VEGF) (58). While the presence of macrophages at CNV lesions is 
recognized, it is still a matter of debate whether macrophages play a pathologic or a 
restorative/adaptive role in AMD. 
Overall, these and other observations strongly suggest that inflammation is an 
important component in the pathogenesis of AMD. 
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1.5. The Ubiquitin-Proteasome Pathway 
 
The ubiquitin-proteasome pathway (UPP) is the major non-lysosomal proteolytic 
pathway within cells (21). In this ATP-dependent pathway, proteins destined for 
degradation must be marked by a multiubiquitin chain in order to be recognized and 
degraded by a large protease complex called the proteasome (21; 65; 66; 67). 
Ubiquitin conjugation, or ubiquitination, is a highly ordered process and involves three 
different classes of enzymes. An ubiquitin-activating enzyme (E1) first activates and 
transfers ubiquitin to an ubiquitin-conjugating enzyme (E2), which then acts with one of 
a large family of ubiquitin protein ligases (E3) to transfer ubiquitin to a lysine residue in 
the target substrate (21; 66; 68; 69). A chain of at least four ubiquitin moieties is 
required for substrate recognition by the 26S proteasome complex (Figure 7) (21). 
The 26S proteasome complex consists of a 20S catalytic core and two regulatory 
19S caps (21; 70). The 20S particle is comprised of four heptameric rings arranged 
coaxially. The subunits of the 20S core are classified into α and β, with the non-
catalytic α-heptameric rings forming each of the two outer rings and the catalytic β-
heptamers forming the two inner rings (65; 71). The β-subunits contain three pairs of 
active sites that perform distinct proteolytic activities. The active sites have been 
classified as caspase-like, trypsin-like and chymotrypsin-like for cleavage of acid, basic 
and hydrophobic amino acids, respectively (65; 71). The 19S caps are responsible for 
the recognition of ubiquitinated substrates and subsequent cleavage of the ubiquitin 
moieties from those substrates. The protein subunits present in the 19S cap also play 
an important role in unfolding the protein substrate and feeding it through the 
proteolytic chamber of the 20S core (21; 72). 
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The UPP is an essential protein quality control system, which selectively 
degrades mutant, misfolded or damaged proteins (21; 73; 74). Timely removal of 
abnormal or damaged proteins by the UPP is essential for the cells to recover from 
various environmental stresses. However, the UPP itself is a target of such stresses 
(21; 65; 66; 73; 75). All the three classes of ubiquitination enzymes have a cysteine in 
their active sites, and therefore, their activities are subject to redox regulation. In 
addition, other types of modifications, such as S-nitrosylation, can inactivate these 
enzymes (21; 66). ROS and reactive lipid peroxidation products, such as 4-
hydroxynonenal (HNE), can also impair the activity of the proteasome (73; 75; 76).  
 
1.5.1. Oxidative inactivation of the UPP: a molecular link between 
oxidative stress and AMD 
 
Given that the UPP is involved in virtually every aspect of cellular function, it is 
not surprising that impairment of this pathway is associated with the development of 
several pathologies. Indeed, an age-related decline in proteasome activity has been 
implicated in many age-related diseases, such as AMD (66; 68; 71; 73).  
Figure 7: The ubiquitin-proteasome pathway (UPP). A cascade of enzymatic reactions 
leads to ubiquitination of lysine residues of the substrate. Adapted from Meusseur et al (137). 
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The UPP has been involved in a myriad of cellular processes (21; 68; 73), 
including regulation of signal transduction pathways involved in angiogenesis, 
regulation of immune response and inflammation. 
The hypoxia-inducible factor (HIF) is a key regulator of a wide range of hypoxia-
related processes, including angiogenesis (77). Both HIF-1α and HIF-1β subunits exist 
as a series of isoforms encoded by distinct genetic loci. HIF-1β subunits are 
constitutive nuclear proteins, whereas HIF-1α subunits are induced by hypoxia. The 
abundance of HIF-1α subunits is mainly regulated by the rate of degradation. Oxygen-
dependent hydroxylation at two proline residues (Pro402 and Pro564) of human HIF-1α 
mediates its interactions with an ubiquitin ligase (E3), von Hippel-Lindau (VHL), which 
targets HIF-1α for proteasomal degradation (78; 79), and contributes to the extremely 
rapid proteolysis of HIF-1α in cells under normoxia conditions (80). 
In addition to HIF, other transcription factors, such as nuclear factor κB (NF-κB) 
are under the control of the UPP. NF-κB proteins are present in the cytoplasm in 
association with inhibitory proteins called inhibitors of κB (Ι-κB). Upon activation by a 
variety of stimuli, the Ι-κB proteins are phosphorylated, ubiquitinated, and subsequently 
degraded by the proteasome. Degradation of Ι-κB allows translocation of NF-κB into 
the nucleus and binding to its cognate DNA binding sites to regulate the transcription of 
a large number of genes, including those involved in angiogenesis and inflammation, 
such as cytokines and stress response proteins (67; 69). 
Given that the UPP is involved in regulating a number of signal transduction 
pathways and transcription factors, including HIF-1α and NF-κB, and its activity can be 
compromised upon oxidative stress (65; 66; 68; 75), it is therefore plausible that age-
related impairment of the UPP in the retina could result in the altered expression of 
genes involved in angiogenesis and inflammation, such as those under the control of 
HIF-1α and NF-κB (81). This UPP impairment would, in turn, act as a link between 
retinal oxidative insult and expression of AMD-like features, such as increased 
inflammation, accumulation of drusen (caused by a decreased macrophage 
recruitment) and neovascularization of the retina (Figure 8). 
Consistent with this hypothesis, we have shown that the proteasome is a target of 
oxidative damage in cultured human RPE cells (66) and that oxidative inactivation of 
the proteasome may provide a link between oxidative stress and increased production 
of pro-inflammatory cytokines, such as IL-8 (68). Furthermore, we have elucidated a 
cascade of sequential activation of signaling pathways in response to proteasome 
inactivation, contributing to an increase in IL-8 production. This cascade is initiated by 
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proteasome inhibition and involves a downstream activation of MKK3/MKK6, p38 
MAPK activation, EGFR phosphorylation, PI3K activation and increased IL-8 
expression. Furthermore, we have identified the Itk kinase as a novel regulator of IL-8 
expression upon proteasome inhibition (82). 
Consistent with a model for AMD-like phenotypes, our studies also show that 
impairment of the proteasome in RPE increases the production of proangiogenic 
factors, such as VEGF. This increase is mediated by HIF-1α, which is stabilized upon 
proteasome inhibition in RPE (72). On the other hand, proteasome inactivation in RPE 
decreases NF-κB activation and, consequently, attenuates MCP-1 production, an 
important player in macrophage recruitment to the retina. Interestingly, mice lacking 
MCP-1 or its cognate receptor, CCR-2, develop features of human AMD (64). 
Further support for an involvement of the proteasome in the pathogenesis of 
AMD comes from recent studies that show a change in proteasome activity in the eyes 
from AMD patients (26; 71).  
Given the function of the UPP in regulating IL-8, VEGF, and MCP-1 in RPE cells 
and the roles of these chemokines and growth factor in the pathogenesis of AMD, 
impairment of the UPP in RPE could significantly contribute to the development of AMD 
(21; 68; 82).  
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1.6. Cholesterol and its oxidation products: relevance for 
AMD 
 
Cholesterol is an essential component of mammalian membranes (83; 84; 85). It 
alters membrane fluidity, thickness, curvature and permeability (84). In addition, 
cholesterol is an important constituent of lipid rafts, and because of the large number of 
signaling proteins that are localized in these structures, it has been postulated that 
these domains serve as regulatory platforms for some transduction pathways (84; 86; 
87; 88). Nevertheless, excess cholesterol is toxic to cells. Therefore, its levels must be 
tightly regulated (86). 
Figure 8: The hypothesized relationship between oxidative impairment of the UPP and 
AMD. Oxidative stress may inactive the UPP in RPE cells. Impairment of the UPP in RPE cells 
will decrease the activity of NF-κB (by stabilization of I-κB) and enhance the activity of the HIF 
system by stabilization of HIF-1α, resulting in VEGF overexpression. On the other hand, 
proteasome inactivation may also result in the activation of a cascade of sequential activation of 
signaling pathways, including p38 MAPK, EGFR and PI3K. These changes will result in altered 
expression of genes involved in AMD-like phenotypes (82).  
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Cholesterol is synthesized in the endoplasmic reticulum (ER) and delivered to 
other organelles by both vesicular and non-vesicular transport processes (89). Some 
other sources of cellular cholesterol include endocytic uptake of lipoproteins and 
hydrolysis of their cholesterol esters in late endosomes and lysosomes (89; 90).  
As a hydrophobic molecule, cholesterol must be transported into the plasma by 
carriers (91). These carriers are classified, according their density, into four main 
classes: chylomicrons, low-density lipoproteins (LDL), high-density lipoproteins (HDL) 
and very-high-density lipoproteins (VHDL) (83). LDL is the primary carrier of cholesterol 
in the blood and delivers cholesterol to peripheral tissues, whereas HDL is involved in 
the process of reverse cholesterol transport from peripheral tissues to the liver (83). 
Cholesterol is composed of three regions: a hydrocarbon tail (also called lateral 
chain), a ring structure region with four hydrocarbon rings (A, B, C and D), and a 
hydroxyl group (92). Cholesterol is easily oxidized and this reaction may occur in the 
ring of the structure or in the lateral chain, resulting therefore in the formation of 
oxysterols, a large class of 27-carbon atom molecules (92).  
Although oxysterols are less abundant than cholesterol, they are absorbed more 
rapidly in the intestine, have a faster plasma clearance and are quickly collected by 
tissues, when compared to cholesterol (92). 
Oxysterols may be formed enzymatically, such as 25-hydroxycholesterol (25-
OH), or as a result of auto-oxidation of cholesterol, such as 7β-hydrocholesterol (7β-
OH) and 7-ketocholesterol (7-KC), during the oxidation of the LDL particle (Figure 9) 
(93; 94). It should be noted that cholesterol auto-oxidation can also take place in 
various tissues (92). The microsomal cytochrome P450 system is the main enzyme 
complex involved in the enzymatic formation of oxysterols; however, some other 
enzymes may be involved in this process. For instance, 25-OH is generated by 
cholesterol 25-hydroxylase (92). 
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In addition to being intermediates in the cholesterol biosynthetic pathway, 
oxysterols have been shown to possess many important and diverse biochemical and 
regulatory activities (86; 95; 96; 97; 98; 99; 100; 101). In fact, an increasing body of 
literature demonstrates that oxysterols may have cytotoxic, oxidative and inflammatory 
effects in a variety of cell types (96; 102; 103). 7-KC and 7β-OH are considered the 
most cytotoxic oxysterols, whereas 25-OH has been shown not to be as toxic as these 
two (92). The different structure of oxysterols and their different affinities for oxysterol-
binding proteins may explain the distinct biological activities observed with different 
oxysterols (104). 
Given that the aging process is usually characterized by an increase in the 
production of oxidized compounds, it is not surprising that an age-dependent 
accumulation of oxysterols, as cholesterol oxidation products, has been reported in 
several tissues, including the lens and the retina (105; 106; 107). Furthermore, 
oxysterols have been associated with the development of many age-related diseases, 
such as cataract, atherosclerosis and AMD (94; 108; 109). The inflammatory properties 
Figure 9: Chemical structures of cholesterol, 25-hydroxycholesterol, 7-ketocholesterol 
and 7β-hydroxycholesterol. Adapted from Brown et al. (108) and Lordan et al. (109). 
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of oxysterols may account for the inflammatory component of these age-related 
diseases (92; 94; 96). 
Although oxysterols have been shown to have inflammatory properties by 
triggering the production of pro-inflammatory cytokines in several cell types, including 
the RPE (92; 110; 111; 112; 113), the molecular mechanisms underlying this increased 
production are still unclear. 
 
1.7.  Objectives  
 
Age-related macular degeneration (AMD) is the leading cause of blindness in the 
western world in the population over 60 years of age (6; 13).  
An increasing body of literature indicates that AMD is related to the dysfunction of 
the RPE (27; 39). Furthermore, recent findings suggest a role for inflammation in the 
pathogenesis of AMD (21; 45; 51; 56). However, the molecular mechanisms underlying 
the development of the disease are still far from understood. 
Oxysterols, the products of cholesterol oxidation, have been shown to increase 
the production of pro-inflammatory cytokines, such as IL-8, in several cell types (92; 
110; 111). Moreover, previous reports, including work from our laboratory, have 
demonstrated an age-related accumulation of oxysterols in ocular tissues, such as the 
lens and the retina (105; 106; 107) 
Therefore, the first aim of this study was to test the effect of oxysterols on IL-8 
production in cultured RPE. We investigated whether different oxysterols known to 
have pro-inflammatory properties increased IL-8 expression and secretion in a RPE 
cell line. 
Our recent studies suggest that the oxidative inactivation of the proteasome can 
constitute a molecular link between oxidative stress and increased IL-8 production in 
RPE cells (68). Furthermore, oxysterols have been shown to increase the production of 
ROS in cultured RPE (110; 114). Therefore, the second aim of the study was to assess 
whether the increased IL-8 production by oxysterols in the RPE involved impairment of 
the proteasome and whether this was an oxidation-dependent event. 
Finally, having established that oxysterols increase IL-8 production in cultured 
RPE, the third aim of this work was to elucidate the signal transduction pathways 
involved in this up-regulation. 
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Altogether, this study aimed at understanding the molecular mechanisms 
underlying the enhanced IL-8 production induced by oxysterols in cultured RPE. 
By understanding the role of oxysterols in the development of AMD, it might be 
possible to envision new therapeutic approaches to this disease.  
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2. EXPERIMENTAL PROCEDURES 
 
2.1. Materials 
 
Dulbecco’s Modified Eagle’s Medium/ Nutrient Mixture F-12 Ham (DMEM-F12), 
oxysterols (25-OH, 7-KC e 7β-OH), cholesterol, vitamin E, bovine serum albumin 
(BSA), sodium orthovanadate and the monoclonal antibody against actin were obtained 
from Sigma-Aldrich (St Louis, MO, USA). The fetal bovine serum (FBS) and the 
antibiotics for cell culture were purchased from Gibco (Grand Island, NY, USA). 
MG132, U0126, FR180204, LY294002 were purchased to Calbiochem (La Jolla, CA, 
USA). Peptidasefluorogenic substrates Succinyl-Leu-Leu-Val-Tyr-
amidomethylcoumarin (LLVY-AMC), N-t-butyloxycarbonyl-Leu-Ser-Thr-Arg-
amidomethylcoumarin (LSTR-AMC) and benzyloxycarbonyl-Leu-Leu-Glu-
amidomethylcoumarin (LLE-AMC) were from Biomol (Plymouth Meeting, PA, USA). 
SDS-PAGE reagents and the nitrocellulose membrane for Western Blot were 
from Bio-Rad Laboratories (Hercules, CA, USA). Rabbit polyclonal antibodies to 
phosphorylated ERK1/2 (extra-cellular signal regulated kinase) and total ERK1/2 were 
purchased from Cell Signaling Technology (Danvers, MA, USA). Horseradish 
peroxidase (HRP)-conjugated goat anti-rabbit IgG and sheep anti-mouse IgG were 
from Zymed Laboratories Inc. (San Francisco, CA, USA). The ECL Western Blotting 
detection kit was obtained from Amersham Biosciences (Buckingamshire, UK). The 
DuoSet ELISA kit for IL-8 was obtained from R&D Systems (Minneapolis, MN, USA).  
The RNA RNeasy mini kit and the SYBR Green PCR Master Mix were from 
Qiagen (Valencia, CA, USA). 
All other chemicals were obtained from Sigma and were of the highest purity 
available. 
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2.2. Cell culture and treatments 
 
The retinal pigment epithelial cell line ARPE-19 (115) was obtained from 
American Type Culture Collection (Manassas, VA, USA). The cells were routinely 
maintained at 37ºC under 5% CO2 atmosphere and cultured in DMEM:F12 
supplemented with 10% FBS and containing 100 U/mL penicillin G and 100 µg/mL 
streptomycin. 
Before treatments, confluent cells were rinsed once with Phosphate-buffered 
saline (PBS) and fresh medium was added. For Western Blot assays, the medium was 
changed the day before the incubations. 
The different oxysterols (25-OH, 7-KC, 7β-OH) and cholesterol were prepared in 
ethanol at 10 mg/mL and diluted to 20 µg/mL (50 µM) in the cell medium immediately 
before use. Cells incubated only with the vehicle (ethanol) were used as a control. 
U0126, FR180204 and LY294002 were prepared in dimethyl sulfoxide (DMSO) at 10 
mM and diluted to 10 µM in the cell medium just prior to use. Controls included cells 
incubated only with the vehicle (DMSO). In all experiments, the inhibitors were added 
to the cell medium 1 hour before the treatments. For proteasome inhibition studies, 
MG132 was prepared in DMSO at 10 mM and diluted to 20 µM in cell medium 
immediately before use. Vitamin E (α-tocopherol) was prepared in DMSO at 50 mg/mL 
and then diluted to 5 µg/mL just prior to use. Vitamin E was added to the cell medium 6 
hours before the treatments. 
 
2.3. Western Blot 
 
Whole cell lysates were prepared for Western blot analysis. Following treatment, 
cells were rinsed once with ice-cold PBS supplemented with 2 mM of sodium 
orthovanadate (phosphatase inhibitor) and then scrapped and collected in Laemmli 
buffer. Cell lysates were then denatured at 100ºC for 5 min and solubilized by 
sonication for 3 time periods of 5 seconds. The denatured proteins were separated by 
electrophoresis in a 10-12% polyacrylamide gel containing sodium dodecyl sulfate 
(SDS-PAGE). Proteins in the gel were then transferred to nitrocellulose membranes, 
during 1 hour at 100V. Next, membranes were blocked in 5% milk during 1 hour at 
room temperature and then probed with rabbit polyclonal antibodies to phosphorylated 
ERK1/2 and total ERK1/2 (1:1000 in TST containing 5% of BSA) or mouse monoclonal 
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antibody to β-actin (1:10000 in TST containing 5% of milk) and incubated overnight at 
4ºC. After incubation for 1 hour at room temperature with the corresponding HRP-
conjugated secondary antibody, the proteins were visualized using ECL Western 
Blotting Detection kit, following the manufacturer’s instructions. Exposure times were 
adjusted so that the band intensity fell within the linear range of detection. 
 
2.4. Enzyme-linked immunosorbent assay (ELISA) 
 
Levels of IL-8 secreted into the medium by RPE were determined by ELISA. The 
medium was diluted 10 times to determine IL-8 levels. All ELISAs were performed 
according to manufacturer’s instructions. Briefly, a monoclonal antibody against IL-8 
was diluted to the working concentration in PBS without the carrier protein and a 96-
well plate was coated with 100 µL of the diluted antibody per well. The plate was 
incubated overnight at room temperature. The samples were added to the plate and 
incubated at room temperature for 2 hours. After the incubation, a biotinylated 
polyclonal antibody against IL-8 was added and incubated overnight at 4ºC. After 
incubation with streptavidin-HRP for 20 minutes at room temperature, the TMB 
substrate Chromogen solution was added and incubated at room for 20 minutes, 
protecting the plate from direct light. The reaction was stopped by adding H2SO4 1M 
and the optical density of each well was determined using a microplate reader set to 
450 nm. 
 
2.5. Real-time RT- PCR 
 
Total RNA was extracted from ARPE-19 cells using the RNeasy mini kit 
according to the instructions of the manufacturer. The amount of total RNA was 
determined by absorbance at 260 nm and its purity was assessed by the 260/280 nm 
ratios. For first strand cDNA synthesis, 2 µg of total RNA from each sample were 
reverse-transcribed with SuperScriptase III, using Random Primers (300 ng), dNTPs 
(0.5 mM each), RT buffer (1x) and DTT (0.01 M) in a total volume of 20 µL. The 
reaction was performed at 25ºC for 10 minutes, followed by 50 minutes at 42ºC, for 
primer annealing to the RNA template and cDNA synthesis, respectively. The reaction 
was terminated at 70ºC for 15 minutes, and the samples were cooled to 4ºC and stored 
at -20ºC until further use.  
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Real-time RT-PCR analysis was conducted on ABI PRISM 7000 sequence 
detection system from Applied Biosystems using SYBR Green PCR master mix 
according to the manufacturer’s instructions. The primers used for amplification of the 
IL-8 gene are as follows: the forward primer was: 5'-AAACCACCGGAAGGAACCAT-3’ 
and the reverse primer was: 5'-CCTTCACACAGAGCTGCAGAAA-3’. Levels of GAPDH 
were used for normalization of the total mRNA amount. For quantification of GAPDH 
mRNA, the forward primer was 5’-ATCACCATCTTCCAGGAGCGA-3’ and the reverse 
primer was 5’-CCTTCTCCATGGTGGTGAAGAC-3’. Each primer of a pair was added 
to the reaction mixture (final volume: 25 µL) at a final concentration of 25 µM, in 
addition to the SYBR Green PCR master mix (1x) and 1 µl of cDNA sample. The 
thermal cycling was initiated by denaturation during 10 minutes at 95ºC followed by 45 
cycles of a 30 s melting step at 95ºC, a 5 s annealing step at 58ºC and a 25 s 
elongation step at 72ºC. After amplification for 45 cycles, samples were subjected to a 
melting curve analysis in order to confirm the absence of unspecific amplification 
products and primer dimers. The relative changes in the mRNA levels of the genes 
tested were determined by the ∆∆Ct method. The “Cycle threshold” (Ct) values for 
each target gene given by the ABI PRISM 7000 sequence detection system software 
were subtracted by the respective Ct value determined for the GAPDH gene from the 
same sample and condition (∆Ct), in order to normalize for changes in target gene 
expression. The ∆Ct values were subsequently subtracted by the respective values of 
the control for the target gene giving ∆∆Ct. The derivation to the formula 2-(∆∆Ct) sets 
each control at the unity (or 100%), since ∆∆Ct (control) = 0, and the different 
experimental conditions at a percentage relative to the control. 
 
2.6. Proteasome Activity Assay 
 
ARPE-19 cells were lysed in 25 mM Tris-HCl buffer, pH 7.6. All three peptidase 
activities of the proteasome were determined using fluorogenic peptides, as described 
(65). LLVY-AMC was used for the chymotrypsin-like activity, LSTR-AMC was used for 
the trypsin-like activity, and LLE-AMC was used for the caspase-like activity. The 
mixture, containing 20 µL of cell supernatant in 25 mM Tris-HCl, pH 7.6, was incubated 
at 37 °C with the appropriate concentrations of  peptide substrate (LLVY-AMC at 25 
µM, LLE-AMC and LSTR-AMC at 40 µM) in a buffer containing 50 mM Tris-HCl, pH 
8.0, 100 mM NaCl, 5 mM EDTA, 1 mM EGTA, 3 mM NaN3 and 0.04% 3-[(3-
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Cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS). The final volume of 
the assay was 200 µL. Rates of reactions were measured in a temperature-controlled 
microplate fluorometric reader. Excitation wavelength was 380 nm and emission 
wavelength was 460 nm. Proteasome activity was defined as portion of peptidase 
activity in the cell extracts that was inhibited by 20 µM N-Cbz-Leu-Leu-leucinal 
(MG132), a proteasome inhibitor (116). 
2.7. Statistical Analysis 
 
Statistical analysis was performed using GraphPad Prism Version 4.00 software 
(GraphPad Software Inc., U.S.A.). All the results are representative of at least three 
independent experiments. Data are expressed as mean ± standard deviation (SD). 
Comparisons between multiple groups were performed with an one-way ANOVA 
followed by a Tukey’s test or Student’s t-test (Figure 10C).Significance was accepted at 
p<0.05. 
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3. RESULTS 
 
3.1. 25-OH increases IL-8 production in the RPE 
 
A number of studies highlight the role of inflammation in the development of AMD 
(21; 45; 51; 56). Furthermore, oxysterols have been shown to accumulate in ocular 
tissues, such as the lens and retina, in an age-related manner (105; 106; 107) and to 
increase the production of pro-inflammatory cytokines, such as IL-8, in several cell 
types (110; 111; 117). 
To investigate the potential link between oxysterols and inflammation, we 
determined the effect of several oxysterols on the secretion of IL-8, a pro-inflammatory 
cytokine. The oxysterols tested were selected based on previous studies that have 
shown their ability to induce inflammatory gene expression in other cell types (93; 102).  
As shown in Figure 9A, incubation of ARPE-19 cells with 25-OH resulted in a 2-
fold increase in the secretion of IL-8. This effect seems to be specific for 25-OH, as 
incubation of ARPE-19 cells with both 7-KC and 7β-OH did not increase IL-8 
production (Figure 10A). In fact, both oxysterols slightly decreased IL-8 production, 
when compared with the control (Figure 10A). To rule out the possibility that the 
increased IL-8 secretion following 25-OH treatment was due to the cholesterol 
molecule itself, an additional control included the incubation of ARPE-19 cells with 
cholesterol. As shown in Figure 10B, cholesterol did not have a significant effect on IL-
8 secretion in ARPE-19 cells, whereas 25-OH was able to increase IL-8 production. 
Consistent with the protein levels, incubation of ARPE-19 cells with 25-OH dramatically 
increased IL-8 mRNA levels (Figure 10C).     
Taken together, these data indicate that 25-OH leads to an up-regulation of IL-8 
production in RPE.  
 
 
25-Hydroxycholesterol increases IL
activation of 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: 25-OH increases IL
with 7-KC (20 µg/mL), 7β-OH (20 µg/mL), 25
hours. IL-8 protein levels in the 
levels for IL-8 were determined by real time RT
mean±S.D of three independent experiments.  ***p<0.001
control; #p<0.001 as compared with cholesterol. 
-8 production in retinal pigment epithelial cells by 
PI3K and ERK pathways 
 
-8 production in RPE cells. ARPE-19 cells were incubated 
-OH (20 µg/mL) and cholesterol (20 µg/mL) for 24 
medium were determined by ELISA (panels A and B). mRNA 
-PCR (panel C). Results are presented as the 
 and * p<0.05 as compared with 
 
26 
25-Hydroxycholesterol increases IL-8 production in retinal pigment epithelial cells by 
activation of PI3K and ERK pathways 
 
27 
 
3.2. 25-OH does not affect proteasome activity in RPE  
 
We have recently shown that oxidative inactivation of the proteasome is a 
mechanistic link between oxidative stress and up-regulation of IL-8 production in RPE 
cells (65; 66; 68). Moreover, a recent report indicates that oxysterols induce ROS 
production in the RPE (110). Therefore, it is conceivable that 25-OH increases IL-8 
production in RPE by the oxidative inactivation of the proteasome. To test this 
hypothesis, we assessed the effect of 25-OH on proteasome activity in ARPE-19 cells.   
As shown in Figure 11, 25-OH did not have a significant effect on any of the three 
proteolytic activities of the proteasome. MG132, a potent proteasome inhibitor, was 
used as a positive control. The minor inhibitory effect of MG132 towards the trypsin-like 
activity of the proteasome may be due to a higher selectivity of this inhibitor for the 
other two activities (118; 119). 
Together, these results demonstrate that 25-OH does not affect proteasome 
activity in the RPE. 
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3.3. 25-OH-induced IL-8 production in RPE is not 
associated with increased oxidative stress 
 
A number of studies suggest that oxidative stress can trigger an inflammatory 
response in several cell types, including the RPE (36; 37; 61; 68). Consistent with 
these observations, we have recently shown that oxidative stress can increase the 
production of IL-8, an important pro-inflammatory cytokine, in ARPE-19 cells (68). 
Given that a previous report (110) and our preliminary data indicate that oxysterols can 
induce the production of ROS in the RPE, we assessed whether the increased IL-8 
production following 25-OH treatment was an oxidative event.  
Consistent with our previous results, 25-OH increased IL-8 production in ARPE-
19 cells (Figure 12). However, pre-incubation with vitamin E did not prevent 25-OH-
induced IL-8 production, suggesting that this effect is not due to increased oxidative 
stress. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: The increased IL-8 production induced by 25-OH is not suppressed by 
antioxidants. ARPE-19 cells were preincubated with Vitamin E (Vit E) (5 µg/mL) for 6 hours and 
then exposed to 25-OH (20 µg/mL) for 24 hours. IL-8 protein levels in the medium were 
determined by ELISA. Results presented are the mean of two independent experiments. 
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3.4. 25-OH activates ERK in RPE in a PI3K-dependent 
manner 
 
The data above indicate that 25-OH increases IL-8 production in RPE. Moreover, 
this increase does not involve oxidative stress nor inhibition of the proteasome. 
However, the signaling events underlying the enhanced IL-8 production in response to 
25-OH are still unclear. 
In order to search for the signal transduction pathways that account for the up-
regulation of IL-8 upon 25-OH treatment, we examined the effect of 25-OH on the 
activation of the ERK pathway. This pathway has been shown to regulate IL-8 gene 
expression (111; 113; 117) and ERK can be activated upon various stresses, including 
exposure to oxysterols (111; 113; 117; 120). 
As shown in Figure 13A, phosphorylated ERK was barely detected in control 
cells. However, incubation of ARPE-19 cells with 25-OH resulted in the activation of 
ERK, as assessed by the increased levels of phosphorylated ERK. This effect was 
most pronounced at 12 hours of incubation. In contrast, the total amount of ERK did not 
change in any of the experimental conditions. Interestingly, 25-OH seems to primarily 
activate ERK2. In fact, after a long exposure, we were able to detect a second band, 
probably corresponding to ERK1 (Figure 13B), suggesting that 25-OH activates both 
ERK isoforms to different extents. 
To rule out the possibility that the ERK activation following 25-OH treatment was 
due to the cholesterol molecule itself, an additional control included the incubation of 
ARPE-19 cells with cholesterol. As shown in Figure 13C, cholesterol did not have a 
significant effect on ERK activation in ARPE-19 cells, whereas 25-OH was able to 
activate ERK. This is consistent with our previous results showing that cholesterol did 
not have a significant effect on IL-8 production (Figure 10B) and further suggests a 
requirement for ERK activation in the increased IL-8 production in RPE cells upon 25-
OH treatment. 
The data above suggest that 25-OH activates ERK in RPE cells. However, the 
upstream signaling events leading to this activation are still unclear.   
To determine the upstream events that trigger the activation of ERK1/2 in 
response to 25-OH, we assessed the effect of PI3K inhibition on ERK activation under 
these conditions. The PI3K pathway has been shown to activate ERK in other cell 
types (86; 121). Therefore, it is conceivable that the 25-OH-induced ERK activation in 
RPE cells is PI3K-dependent.  
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3.5. 25-OH increases IL-8 production in RPE in a PI3K- and 
ERK-dependent manner 
 
The data presented so far suggest that 25-OH up-regulates IL-8 and activates 
ERK in a PI3K-dependent manner in RPE. To further test the causal relationship 
between PI3K and ERK activation and up-regulation of IL-8 in response to 25-OH, we 
evaluated the effect of PI3K and ERK inhibitors on IL-8 production after 25-OH 
treatment. 
As shown in Figure 14A, 25-OH up-regulated IL-8 production in RPE cells. 
Remarkably, LY294002, a PI3K inhibitor, was able to prevent the IL-8 up-regulation 
induced by 25-OH. Even in control cells, LY294002 led to a decrease in IL-8 secretion 
in RPE cells.  
Moreover, blocking the ERK pathway by using different inhibitors of this pathway 
(U0126 and FR180204) also prevented the enhanced IL-8 production triggered by 25-
OH (Figure 14B and 14C). A control blot confirmed the inhibition of ERK 
phosphorylation by U0126 and FR180204 (Figure 14D). 
Taken together, these data strongly suggest that the activation of PI3K and ERK 
plays a major role in the up-regulation of IL-8 production following 25-OH treatment. 
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4. DISCUSSION 
 
AMD is the main cause of blindness in the elderly population (usually over 60 
years old) in the western world (13). Although the cause of AMD is currently unknown, 
it has been suggested that multiple factors, including genetic, nutritional and 
environmental factors, are involved in the development of this pathology (4; 5; 6; 8; 14; 
13). Most of the known risk factors for AMD, including environmental and nutritional 
factors, appear to have oxidative stress as a common denominator (5; 13; 20; 23). 
Recent findings further suggest a role for inflammation in the pathogenesis of 
AMD (28; 31; 45; 46). 
The activation of redox-sensitive transcription factors may be involved in 
triggering the expression of pro-inflammatory cytokines, such as IL-8, thus providing a 
link between oxidative stress and inflammation upon aging (21; 47; 48). Further support 
for this link between oxidative stress and inflammation in AMD comes from a recent 
study demonstrating that oxidative damage-induced inflammation initiates AMD (122). 
However, the molecular mechanism(s) linking oxidation to inflammation in this 
pathology is still unclear.  
We have recently shown that the oxidative inactivation of the proteasome may be 
a mechanistic link between oxidative stress and increased production of pro-
inflammatory cytokines, such as IL-8 (21; 68; 82). 
However, the fact that pro-inflammatory cytokines, such as IL-8, can be regulated 
by both oxidative and non-oxidative mechanisms adds a new layer of complexity in 
understanding the molecular mechanisms underlying AMD. In fact, we have also 
demonstrated that A2E, a major fluorophore of lipofuscin, induces the secretion of IL-8 
in RPE, even though it does not cause detectable oxidative damage or proteasome 
inhibition (68). 
Oxysterols, or cholesterol oxides, have been shown to increase IL-8 production in 
several cell types and, thus, have been implicated in many age-related diseases with a 
strong inflammatory component (110; 111; 117). Moreover, previous reports, including 
work from our laboratory, have demonstrated an age-related accumulation of 
oxysterols in ocular tissues, such as the lens and the retina (105; 107; 106). 
However, the molecular mechanisms underlying the production of IL-8 under 
these conditions remain unclear. 
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The data presented in this thesis show that exposing ARPE-19 cells to 25-OH 
results in the increase of IL-8 gene expression and secretion (Figure 10). 25-OH also 
activates PI3K and ERK (Figure 13). Consistent with this observation, inhibiting either 
one of these pathways prevented the 25-OH-induced IL-8 production in RPE cells 
(Figure 14). Together, these data indicate that 25-OH up-regulates IL-8 production in 
RPE cells by a mechanism dependent on PI3K and ERK activation, as illustrated in 
Figure 15. In this model, 25-OH activates PI3K by a yet unknown mechanism. 
Activation of PI3K will result in the phosphorylation and consequent activation of ERK. 
ERK will then recruit a yet unknown transcription factor, which in turn will lead to an 
increase in IL-8 gene expression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
From all the oxysterols tested, 25-OH was the one with the most pronounced 
effect in terms of IL-8 secretion (Figure 10A). These data are consistent with previous 
Figure 15: Schematic model of a possible molecular mechanism regulating IL-8 
production in response to 25-OH in RPE cells. In this model, 25-OH leads to PI3K activation 
through a yet unknown mechanism. Once activated, PI3K phosphorylates and consequently 
activates ERK. Activation of ERK will recruit a yet unknown transcription factor, which in turn will 
lead to an increase in IL-8 gene expression. 
25-Hydroxycholesterol increases IL-8 production in retinal pigment epithelial cells by 
activation of PI3K and ERK pathways 
 
36 
 
reports that demonstrate that this oxysterol is the most potent inducer of pro-
inflammatory gene expression. The fact that the other oxysterols tested (7-KC and 7β-
OH) decreased IL-8 levels in RPE cells may be explained by their cytotoxicity. In fact, 
several reports have consistently shown that these oxysterols are more cytotoxic than 
25-OH (110; 111). 
This work also demonstrates that the increased IL-8 production in ARPE-19 cells 
induced by 25-OH is independent of oxidation (Figure 12). This is consistent with a 
recent report, which demonstrated that addition of vitamin E did not prevent IL-8 
production induced by 25-OH in ARPE-19 cells (110). 
Furthermore, the present study also indicates that 25-OH does not have an effect 
on proteasome activity in RPE cells (Figure 11). Together, these results indicate that 
25-OH increases IL-8 production in the RPE by a mechanism that does not involve 
oxidative stress nor inhibition of the proteasome. This is consistent with the existence 
of non-oxidative mechanisms regulating IL-8 production under stress conditions (68). 
The increased IL-8 production in ARPE-19 cells upon 25-OH exposure results 
from ERK activation. This effect seems to be specific for ERK, as 25-OH did not have 
any effect on the activation of other MAPKs tested, such as p38 MAPK or JNK. 
Consistent with this, a recent study has demonstrated a similar effect on macrophages 
(113). 
The mechanism whereby 25-OH activates PI3K and, consequently, ERK 
activation is still not clear. 
A possible candidate to mediate the effects of 25-OH in RPE cells is OSBP 
(Oxysterol Binding Protein). OSBP are a family of sterol-binding proteins implicated in 
various cellular processes, such as vesicle transport, lipid metabolism, and signal 
transduction (123) Interestingly, 25-OH has been shown to be the oxysterol that binds 
OSBP with the highest affinity (123; 124). Moreover, a recent study has uncovered an 
important role for OSBP in ERK activation (125). It is therefore possible that OSBP may 
be mediating the effects of 25-OH in the activation of this signaling pathway. 
Another plausible mechanism to explain the effects of 25-OH may be its capacity 
to interfere with cholesterol homeostasis. In fact, several studies suggest that 25-OH 
may induce alterations in the lipid rafts in the membranes of cultured cells (98; 110). In 
addition, cholesterol depletion from the membranes results in the PI3K-mediated ERK 
activation (126). It is therefore possible that 25-OH exerts its effects by depleting 
membrane cholesterol. 
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The transcription factors involved in the enhanced IL-8 production under these 
conditions remain unknown.  
IL-8 gene expression is regulated by several transcription factors, such as NF-κB 
and AP-1 (61; 127). Preliminary data from our laboratory suggests that NF-κB is not 
involved in the increased IL-8 production induced by 25-OH, as inhibition of this 
pathway does not have a significant effect on IL-8 levels under these conditions. This is 
consistent with several reports that described a minor role for NF-κB in the regulation 
of IL-8 production upon oxysterol treatment (74). 
A plausible candidate mediating IL-8 expression following 25-OH exposure is the 
transcription factor AP-1. AP-1 has been involved in the regulation of IL-8 expression in 
several cell types (61; 74; 127). Moreover, a recent study suggests that 25-OH 
increases IL-8 production in macrophages through AP-1 activation (113). 
Another possible candidate responsible for the increased IL-8 production under 
these conditions is the Liver X receptor (LXR). LXR belong to the nuclear hormone 
receptor family and some LXR isoforms are activated by oxysterols (110). Furthermore, 
LXR have been shown to up-regulate IL-8 production in atherosclerosis (110), so it is 
plausible that they may play a role in the regulation of IL-8 expression in RPE cells 
following 25-OH exposure (110; 128). 
Taken together, the results presented in this thesis elucidate a novel signaling 
network that leads to overproduction of IL-8 in response to 25-OH. However, further 
work is required to elucidate the molecular mechanisms underlying the increased IL-8 
production under these conditions. This information will not only shed light onto 
understanding how 25-OH triggers IL-8 production, but also will provide clues how to 
control IL-8 production in order to reduce inflammation and inflammation-related 
diseases. 
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